Modulation of the coagulation system during severe streptococcal disease

Current Topics in Microbiology and Immunology

Volumn 368, Issue , 2013, Pages 189-205

  Shannon, Oonagh ^a   Herwald, Heiko ^a   Oehmcke, Sonja ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; CLINDAMYCIN; COMPLEMENT COMPONENT C1S INHIBITOR; DROTRECOGIN; H KININOGEN; HEPARIN; KININ; KININOGEN; M PROTEIN; PAM RELATED PROTEIN; PLASMINOGEN; PLASMINOGEN BINDING GROUP A STREPTOCOCCAL M PROTEIN; PROTEIN M1; STREPTOCOCCAL ENOLASE; STREPTOLYSIN O; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; DISEASE SEVERITY; DOWN REGULATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FIBRINOLYSIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SECRETION; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; TOXIC SHOCK SYNDROME; UNSPECIFIED SIDE EFFECT; ANIMAL; BLOOD; IMMUNOLOGY; METABOLISM; PATHOGENICITY; REVIEW; SECRETION (PROCESS);

ANIMALS; BLOOD COAGULATION; HUMANS; KININS; PLASMINOGEN; PLATELET ACTIVATION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

MLCS; MLOWN;

EID: 84880434656     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2012-283     Document Type: Article

References (101)

1. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR (1998) Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 102:550-560
2. Barker FG, Leppard BJ, Seal DV (1987) Streptococcal necrotising fasciitis: comparison between histological and clinical features. J Clin Pathol 40:335-341
3. Ben Nasr A, Wistedt A, Ringdahl U, Sjöbring U (1994) Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins. Eur J Biochem 222:267-276
4. Ben Nasr AB, Herwald H, Müller-Esterl W, Björck L (1995) Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. Biochem J 305:173-180
5. Ben Nasr A, Herwald H, Sjöbring U, Renné T, Müller-Esterl W, Björck L (1997) Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. Biochem J 326:657-660
6. Bengtson SH, Sandén C, Mörgelin M, Marx PF, Olin AI, Leeb-Lundberg L M F, Meijers J C M, Herwald H (2009) Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system. J Innate Immun 1:18-28
7. Berge A, Björck L (1995) Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270:9862-9867
8. Berge A, Sjöbring U (1993) PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem 268:25417-25424
9. Boxrud PD, Fay WP, Bock PE (2000) Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen. J Biol Chem 275:14579-14589
10. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532-1535
11. Broder CC, Lottenberg R, von Mering GO, Johnston KH, Boyle MD (1991) Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem 266:4922-4928
12. Brosnahan AJ, Schlievert PM (2011) Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J 278:4649-4667
13. Bryant AE, Hayes-Schroer SM, Stevens DL (2003) M type 1 and 3 group A streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells. Infect Immun 71:1903-1910
14. Bryant AE, Bayer CR, Chen R Y Z, Guth PH, Wallace RJ, Stevens DL (2005) Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J Infect Dis 192:1014-1022
15. Castellino F (1979) Unique enzyme-protein substrate modifier reaction-plasmin-streptokinase interaction. Trends Biochem Sci 4:1-5
16. Christensen L, MacCleod CM (1945) A proteolytic enzyme of serum-characterization, activation, and reaction with inhibitors. J Gen Physiol 28:559-583
17. Christner R, Li Z, Raeder R, Podbielski A, Boyle MD (1997) Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis 175:1115-1120
18. Clawsson CC, White JG (1971) Platelet interaction with bacteria I. Am J Pathol 65(2):1-14
19. Cole JN (2006) Trigger for group A streptococcal M1T1 invasive disease. FASEB J 20:1745-1747
20. Cole JN, Barnett TC, Nizet V, Walker MJ (2011) Molecular insight into invasive group A streptococcal disease. Nat Publ Group 9:724-736
21. Cox D, Kerrigan SW, Watson SP (2011) Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 9:1097-1107
22. D'Costa SS, Romer TG, Boyle M D P (2000) Analysis of expression of a cytosolic enzyme on the surface of Streptococcus pyogenes. Biochem Biophys Res Commun 278:826-832
23. de Jong HK, van der Poll T, Wiersinga WJ (2010) The systemic pro-inflammatory response in sepsis. J Innate Immun 2:422-430
24. de la Cadena RA, Laskin KJ, Pixley RA, Sartor RB, Schwab JH, Bedi GS, Colman RW (1991) Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol 260:213-219
25. Esmon CT, Mather T (1998) Switching serine protease specificity. Nat Struct Biol 5:933-937
26. Fein AM, Bernard GR, Criner GJ, Fletcher EC, Good JT, Knaus WA, Levy H, Matuschak GM, Shanies HM, Taylor RW et al (1997) Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group. JAMA 277:482-487
27. Frick I-M, Akesson P, Herwald H, Mörgelin M, Malmsten M, Nägler DK, Björck L (2006) The contact system-a novel branch of innate immunity generating antibacterial peptides. EMBO J 25:5569-5578
28. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 107:15880-15885
29. Furie B, Furie BC (1988) The molecular basis of blood coagulation. Cell 53:505-518
30. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ (1997) Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 23:379-385
31. Herwald H, Cramer H, Mörgelin M, Russell W, Sollenberg U, Norrby-Teglund A, Flodgaard H, Lindbom L, Björck L (2004) M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116:367-379
32. Hess JL, Boyle M D P (2006) Fibrinogen fragment D is necessary and sufficient to anchor a surface plasminogen-activating complex in Streptococcus pyogenes. Proteomics 6:375-378
33. Hoffman M (2003) A cell-based model of coagulation and the role of factor VIIa. Blood Rev 17(Suppl 1):S1-S5
34. *. Crit Care Med 40:770-777
35. Ikebe T, Endoh M, Watanabe H (2005) Increased expression of the ska gene in emm49-genotyped Streptococcus pyogenes strains isolated from patients with severe invasive streptococcal infections. Japan J Infect Dis 58:272-275
36. Johansson D, Shannon O, Rasmussen M (2011) Platelet and neutrophil responses to gram positive pathogens in patients with bacteremic infection. PLoS One 6:e26928
37. Khil J, Im M, Heath A, Ringdahl U, Mundada L, Cary Engleberg N, Fay WP (2003) Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinaseindependent mechanisms. J Infect Dis 188:497-505
38. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589-1596
39. Kurpiewski GE, Forrester LJ, Campbell BJ, Barrett JT (1983) Platelet aggregation by Streptococcus pyogenes. Infect Immun 39:704-708
40. Kuusela P, Ullberg M, Saksela O, Kronvall G (1992) Tissue-type plasminogen activatormediated activation of plasminogen on the surface of group-A, group-C, and group-G streptococci. Infect Immun 60:196-201
41. Lähteenmäki K, Kuusela P, Korhonen TK (2001) Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 25:531-552
42. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K et al (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359-2367
43. Leeb-Lundberg L M F, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77
44. Li Z, Ploplis VA, French EL, Boyle MD (1999) Interaction between group A streptococci and the plasmin (ogen) system promotes virulence in a mouse skin infection model. J Infect Dis 179:907-914
45. Linder A, Johansson L, Thulin P, Hertzén E, Mörgelin M, Christensson B, Björck L, Norrby-Teglund A, Akesson P (2010) Erysipelas caused by group A streptococcus activates the contact system and induces the release of heparin-binding protein. J Invest Dermatol 130:1365-1372
46. Loof TG, Mörgelin M, Johansson L, Oehmcke S, Olin AI, Dickneite G, Norrby-Teglund A, Theopold U, Herwald H (2011a) Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 118:2589-2598
47. Loof TG, Schmidt O, Herwald H, Theopold U (2011b) Coagulation systems of invertebrates and vertebrates and their rolesin innate immunity: the same sideoftwo coins? J Innate Immun 3:34-40
48. Lorente JA, García-Frade LJ, Landín L, de Pablo R, Torrado C, Renes E, García-Avello A (1993) Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103:1536-1542
49. Lottenberg R, Broder CC, Boyle MD, Kain SJ, Schroeder BL, Curtiss R (1992) Cloning, sequence-analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol 174:5204-5210
50. Marcum JA, Kline DL (1983) Species specificity of streptokinase. Comp Biochem Physiol B Comp Biochem 75:389-394
51. Massberg S, Grahl L, von Bruehl M-L, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB et al (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887-896
52. Mattsson E, Herwald H, Cramer H, Persson K, Sjöbring U, Björck L (2001) Staphylococcus aureus induces release of bradykinin in human plasma. Infect Immun 69:3877-3882
53. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28:451-457
54. McKay FC, Mcarthur JD, Sanderson-Smith ML, Gardam S, Currie BJ, Sriprakash KS, Fagan PK, Towers RJ, Batzloff MR, Chhatwal GS et al (2004) Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infect Immun 72:364-370
55. Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona É (2011) Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 91:931-972
56. Oehmcke S, Herwald H (2010) Contact system activation in severe infectious diseases. J Mol Med 88:121-126
57. Oehmcke SM, Ouml rgelin M, Herwald H (2009a) Activation of the human contact system on neutrophil extracellular traps. J Innate Immun 1:225-230
58. Oehmcke S, Shannon O, von Köckritz-Blickwede M, Mörgelin M, Linder A, Olin AI, Björck L, Herwald H (2009b) Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood 114:444-451
59. Oehmcke S, Shannon O, Mörgelin M, Herwald H (2010) Streptococcal M proteins and their role as virulence determinants. Clin Chim Acta 411:1172-1180
60. Oehmcke S, Mörgelin M, Malmström J, Linder A, Chew M, Thorlacius H, Herwald H (2012) Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles. Cell Microbiol 14:107-119
61. Opal SM, Esmon CT (2003) Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 7:23-38
62. Påhlman LI, Mörgelin M, Eckert J, Johansson L, Russell W, Riesbeck K, Soehnlein O, Lindbom L, Norrby-Teglund A, Schumann RR et al (2006) Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 177:1221-1228
63. Påhlman LI, Malmström E, Mörgelin M, Herwald H (2007) M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology (Reading, Engl) 153:2458-2464
64. Pancholi V, Fischetti VA (1992) A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med 176:415-426
65. Pancholi V, Fischetti VA (1998) Alpha-enolase, a novel strong plasmin (ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 273:14503-14515
66. Histidine-rich glycoprotein: The Swiss Army knife of mammalian plasma
67. Pu Q, Wiel E, Corseaux D, Bordet R, Azrin MA, Ezekowitz MD, Lund N, Jude B, Vallet B (2001) Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock. Crit Care Med 29:1181-1188
68. Renné T (2012) The procoagulant and proinflammatory plasma contact system. Semin Immunopathol 34:31-41
69. Rezcallah MS, Boyle M D P, Sledjeski DD (2004) Mouse skin passage of Streptococcus pyogenes results in increased streptokinase expression and activity. Microbiology (Reading, Engl) 150:365-371
70. Sanderson-Smith ML, Walker MJ, Ranson M (2006) The maintenance of high affinity plasminogen binding by group A streptococcal plasminogen-binding M-like protein is mediated by arginine and histidine residues within the a1 and a2 repeat domains. J Biol Chem 281:25965-25971
71. Sanderson-Smith ML, Dowton M, Ranson M, Walker MJ (2007) The plasminogen-binding group A streptococcal M protein-related protein Prp binds plasminogen via arginine and histidine residues. J Bacteriol 189:1435-1440
72. Semeraro N, Ammollo CT, Semeraro F, Colucci M (2012) Sepsis, thrombosis and organ dysfunction. Thromb Res 129:290-295
73. Semple JW, Italiano JE, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11(4):264-274
74. Shannon O, Hertzén E, Norrby-Teglund A, Mörgelin M, Sjöbring U, Björck L (2007) Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol 65:1147-1157
75. Shannon O, Rydengård V, Schmidtchen A, Mörgelin M, Alm P, Sørensen OE, Björck L (2010) Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis. Blood 116:2365-2372
76. Sjöbring U, Ringdahl U, Ruggeri ZM (2002) Induction of platelet thrombi by bacteria and antibodies. Blood 100:4470-4477
77. Smith SA (2009) The cell-based model of coagulation. J Vet Emerg Crit Care (San Antonio) 19:3-10
78. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC (2009) Platelet Colloquium Participants. Platelet functions beyond hemostasis. J Thromb Haemost 7:1759-1766
79. Soehnlein O, Oehmcke S, Ma X, Rothfuchs AG, Frithiof R, van Rooijen N, Mörgelin M, Herwald H, Lindbom L (2008) Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J 32:405-412
80. Sriskandan S, Kemball-Cook G, Moyes D, Canvin J, Tuddenham E, Cohen J (2000) Contact activation in shock caused by invasive group A Streptococcus pyogenes. Crit Care Med 28:3684-3691
81. Stadnicki A, de la Cadena RA, Sartor RB, Bender D, Kettner CA, Rath HC, Adam A, Colman RW (1996) Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat. Dig Dis Sci 41:912-920
82. Sun H (2004) Plasminogen is a critical host pathogenicity factor for group A streptococcal Infection. Science 305:1283-1286
83. Sun H, Wang X, Degen JL, Ginsburg D (2009) Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 113:1358-1364
84. Sun H, Xu Y, Sitkiewicz I, Ma Y, Wang X, Yestrepsky BD, Huang Y, Lapadatescu MC, Larsen MJ, Larsen SD et al (2012) Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc Natl Acad Sci USA 109:3469-3474
85. Svensson MD, Sjöbring U, Bessen DE (1999) Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo. Infect Immun 67:3915-3920
86. Svensson MD, Sjöbring U, Luo F, Bessen DE (2002) Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology (Reading, Engl) 148:3933-3945
87. Takada Y, Takada A (1989) Evidence for the formation of a trimolecular complex between streptokinase plasminogen and fibrinogen. Thromb Res 53:409-415
88. Taylor FB, Bryant AE, Blick KE, Hack E, Jansen PM, Kosanke SD, Stevens DL (1999) Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns. Clin Infect Dis 29:167-177
89. Tillett WS, Garner R L R (1933) The fibrinolytic activity of hemolytic streptococci. J Exp Med 58:485-502
90. van der Poll T, de Boer JD, Levi M (2011) The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis 24:273-278
91. Vandijck DM, Blot S, De Waele Jan J, Hoste EA, Vandewoude KH, Decruyenaere JM (2010) Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung J Acute Crit Care 39:21-26
92. Walker M, McArthur J, Mckay F, Ranson M (2005) Is plasminogen deployed as a virulence factor? Trends Microbiol 13:308-313
93. Wang H, Lottenberg R, Boyle MD (1995a) Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog 18:153-166
94. Wang H, Lottenberg R, Boyle M D P (1995b) A role for fibrinogen in the streptokinase-dependent acquisition of plasmin (ogen) by group-a streptococci. J Infect Dis 171:85-92
95. Werb Z (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442
96. Williams S C P (2012) After Xigris, researchers look to new targets to combat sepsis. Nat Publ Group 18:1001
97. Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, Claus RA, Bauer M, Lösche W (2009) Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets 20:50-57
98. Winram SB, Lottenberg R (1996) The plasmin-binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiology (Reading, Engl) 142:2311-2320
99. Wistedt AC, Ringdahl U, Müller-Esterl W, Sjöbring U (1995) Identification of a plasminogenbinding motif in PAM, a bacterial surface protein. Mol Microbiol 18:569-578
100. Wistedt AC, Kotarsky H, Marti D, Ringdahl U, Castellino FJ, Schaller J, Sjöbring U (1998) Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM. J Biol Chem 273:24420-24424
101. Yakovlev SA, Rublenko MV, Izdepsky VI, Makogonenko EM (1995) Activating effect of the plasminogen activators on plasminogens of different mammalia species. Thromb Res 79:423-428